Prevalence, family, placement. Informed decisions about keloids and scarring.

A keloid is a fibroproliferative scar — the healing process doesn't stop on schedule, fibroblasts keep laying down collagen, and the resulting scar outgrows the original wound boundary and tends to persist or grow over months and years. It's different from a hypertrophic scar (raised but stays inside the wound and often partially regresses), different from a normal irritation bump on a fresh piercing (soft, pink, usually resolves with aftercare and jewelry adjustment), and different from a pyogenic granuloma or contact-dermatitis reaction. Most bumps on a kid's healing piercing are not keloids. A pediatric dermatologist is the right person to confirm whether a bump is a true keloid — not an internet search and not the piercer.

Peer-reviewed dermatology studies (Bayat 2003 review, Ogawa 2010) report higher keloid prevalence in people of African, Afro-Caribbean, East Asian, South Asian, and Hispanic descent than in people of Northern European descent. That is an elevated statistical risk — it is not a rule against piercing. Ear piercing is deeply culturally meaningful in many of the same communities the data highlights, and countless children in those communities are pierced safely every year. What the data supports is an informed conversation — family medical history, prior scarring pattern, placement choice, and (for families with additional risk factors) a pediatric dermatologist consult before a first piercing. Framed honestly, ancestry is one factor among several, not a disqualification.

Ear cartilage — helix, tragus, conch, rook, daith, industrial — is the zone most consistently flagged in the keloid-prevalence literature, and pediatric case reports of cartilage keloids are well represented. Standard earlobe piercings are lower-risk in most populations, though not zero-risk. For a child with elevated keloid risk factors (family history, ancestry signal, prior raised scars), the common-sense path is lobe-only, at least initially, with cartilage deferred pending how the lobes heal and what a pediatric dermatologist says. Chest, upper back, and shoulder are also keloid-prone zones — these aren't typical pediatric piercing sites, but they're worth knowing about for family-history context.

Family history. A first-degree relative (parent, full sibling, grandparent) with a documented keloid from a piercing, surgical incision, or injury is the clearest signal in the dermatology literature that a specific child sits at elevated risk. Ancestry is a statistical factor. Age window (11–30 is the peak incidence range) is another. Prior scarring behavior — a chickenpox scar or immunization-site scar that grew rather than shrank — is a personal-level signal worth flagging. Put all of those together and a pediatric dermatologist can give a risk picture specific to your child, which is more useful than any general population statistic.

We can meaningfully reduce the odds, not eliminate them. The biggest levers: choose lobe over cartilage for a child with elevated risk, use implant-grade titanium or solid gold jewelry (nothing plated, acrylic, or externally threaded), follow professional-studio aftercare strictly (sterile saline 2x/day, no rotating, no peroxide or alcohol, no antibiotic ointments), avoid trauma (keep hair/hats/phones/helmets off the site; don't sleep on the pierced side), and don't touch or twist the jewelry. If a bump appears, photograph it and track it week-by-week — a soft pink bump that stays the same size or shrinks is usually irritation; a firm, darker bump that grows past the wound edge or persists past 8–12 weeks is worth a pediatric dermatologist visit. Early treatment is meaningfully more effective than late treatment.

Don't panic, and don't wait months hoping it resolves on its own. True keloids rarely regress without intervention, and smaller/newer keloids are substantially easier to treat than large/established ones. Book a pediatric dermatologist visit. The first-line treatment is typically intralesional corticosteroid injection (most often triamcinolone acetonide), often paired with silicone gel sheeting and sometimes custom-fit pressure earrings. Laser therapy can help with redness and symptoms. Surgical excision alone has high recurrence rates and is generally reserved for large or symptomatic keloids, always paired with adjuvant treatments. Your piercer is not a medical provider and should be deferring any keloid question to a dermatologist — so should any guide on the internet, including this one. The page you're reading is orientation; the dermatologist makes the call.

Sometimes yes, sometimes no — this is a dermatologist call, not a piercer call, and the honest answer is that it depends on the specific picture. A small, treated, stable lobe keloid that has responded well to corticosteroid injections and silicone sheeting is a different risk profile than an actively growing untreated one. Pediatric dermatology involvement is essentially mandatory. Your child's preference matters too — re-piercing for symmetry isn't a goal worth imposing on a child who isn't asking for it. What we'd counsel against in almost every case: cartilage piercing after a confirmed keloid on the same child. Cartilage recurrence risk is high enough that Apollo's working position is to defer cartilage pending pediatric dermatology sign-off in writing.

It's a conversation we take seriously — ear piercing is culturally and generationally meaningful across many families, and a blanket refusal framed as medical authority isn't appropriate. Apollo's approach is honest: if we see an active keloid on your child, or if a pediatric dermatologist has specifically advised against piercing, or if a cartilage piercing is being requested on a child with a documented keloid elsewhere, we'll share our concern and ask for a pediatric dermatologist consult before we proceed. If your family wants to pierce anyway with dermatologist support, that's a different conversation — one we can often have productively. Apollo informs; Apollo doesn't decide for the family. A studio that refuses outright, without explanation, and without a referral to a pediatric dermatologist, isn't doing the conversation right. Neither is a studio that pierces same-day under pressure with obvious risk flags unexamined.

Partially. The often-cited prevalence figures come from older studies (Bayat 2003 review summarized data from the preceding decades; similar numbers appear in Ogawa 2010 and earlier work). Newer dermatology is more nuanced: sample sizes in the earlier studies were often small or ethnically narrow, the specific numeric ratios vary by study, and genetic/environmental/socioeconomic factors get entangled. What holds up consistently across the literature is the direction — people of African, Afro-Caribbean, and East/South Asian descent do show higher keloid prevalence than people of Northern European descent. What does not hold up is any specific 'X times more likely' number being treated as exact truth. The Skin of Color Society and dermatology journals over the last decade have explicitly pushed for more representative research in this area. The honest summary: elevated risk is real; precise numbers are imprecise; the right response is informed conversation, not a bright-line rule.